(Q33362095)

English

Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Fixed-dose low-molecular-weight heparin for secondary prevention of venous thromboembolism in patients with disseminated cancer: a prospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

venous thromboembolism

1 reference

based on heuristic

inferred from title

author name string

Monreal M

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Zacharski L

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jiménez JA

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Roncales J

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Vilaseca B

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1311-1315

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Secondary prevention of venous thromboembolism: A role for low-molecular-weight heparin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00853.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2004.00853.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33362095&oldid=1587577313"